Hans Jörg Reinhardt
Chairman bij NOVARTIS AG
Vermogen: 67 M $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Vasant Narasimhan | M | 48 |
Novartis Foundation
Novartis Pharma BV
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 19 jaar |
Bill Winters | M | 62 |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | 11 jaar |
Nancy Andrews | M | 65 |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | 9 jaar |
Pravina Ladva | F | - | 7 jaar | |
William Brody | M | 80 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | 15 jaar |
Albert Bourla | M | 62 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Shannon Klinger | M | 53 |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | 11 jaar |
Andreas von Planta | M | 68 |
Novartis Foundation
| - |
Harry Werner Kirsch | M | 59 |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | 21 jaar |
Jacques de Vaucleroy | M | 63 | 7 jaar | |
Kaspar Müller | M | 51 | 14 jaar | |
Karen Gavan | F | 63 | 6 jaar | |
Otmar D. Wiestler | M | 67 |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | 20 jaar |
Nikolaus Blum | M | - |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | - |
Patrice Bula | M | 68 | 5 jaar | |
Larry Zimpleman | M | 72 | 6 jaar | |
Thomas N. Kendris | M | - |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 8 jaar |
Bik Yun Lau | F | 51 | 1 jaar | |
Deanna Ong | F | - | 4 jaar | |
Samir Shah | M | 63 | 20 jaar | |
Frans van Houten | M | 64 | 7 jaar | |
Paul Michael William Tucker | M | 66 | 8 jaar | |
Steffen Lang | M | 57 | 7 jaar | |
Holger Hanselka | M | 63 |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | - |
Joachim Oechslin | M | 54 | 4 jaar | |
Brigitte Meier | F | - | 22 jaar | |
Jay Stuart Ralph | M | 65 | 7 jaar | |
Liz Doherty | F | 67 | 8 jaar | |
Simon Moroney | M | 65 | 4 jaar | |
Velina Peneva | F | - | 7 jaar | |
John Young | M | 60 | 1 jaar | |
Bridgette Heller | F | 62 | 4 jaar | |
Ana de Pro Gonzalo | F | 57 | 2 jaar | |
Marco Gadola | M | 61 | - | |
Lutz Hegemann | M | 58 |
Novartis Foundation
| - |
Peter M. Herzig | M | 69 |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | - |
Ton Büchner | M | 59 | 8 jaar | |
Daniel Hochstrasser | M | 64 | 2 jaar | |
John Dacey | M | 64 | 12 jaar | |
Philip Ryan | M | 68 | 9 jaar | |
Günther Wess | M | - |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | - |
Charles Sawyers | M | 65 | 11 jaar | |
Kees Roks | M | 61 | 2 jaar | |
Samrat Dua | M | 52 | 3 jaar | |
Teresa Jose | F | - |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | - |
Wen Jie Guan | F | - | 8 jaar | |
Shreeram Aradhye | M | 62 | 2 jaar | |
Christian Klee | M | - |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | - |
Jim Pearse | M | - | 3 jaar | |
Pia Tischhauser | F | - | 1 jaar | |
Michael Francis Bacon | M | - | 8 jaar | |
Andreas Berger | M | - | 5 jaar | |
Veronica Scotti | F | - | 6 jaar | |
Wolfgang Plischke | M | 72 |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | 9 jaar |
Ulf Arne Wiinberg | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Aharon Gal | M | 58 | 2 jaar | |
Olivier Brandicourt | M | 68 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Martyn Parker | M | 67 | 18 jaar | |
Cathy Desquesses | F | - | 3 jaar | |
Tapan Durgadas Ray | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Russell Higginbotham | M | - | 6 jaar | |
Paola Ricci | F | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Franziska Broer | F | - |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | 17 jaar |
Hermann Geiger | M | 61 | 15 jaar | |
Ugo di Francesco | M | 63 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Evan M. Beckman | M | - |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | - |
William Bruce Harrison | M | 38 |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | - |
Roger Connor | M | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Jason Richards | M | 55 | 18 jaar | |
Heike Hanagarth | M | 65 |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | - |
Ali Shahkarami | M | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Rolf M. Zinkernagel | M | 80 | 15 jaar | |
Joseph Jimenez | M | 64 | 11 jaar | |
Ronen Tamir | M | 57 | - | |
Thomas Wellauer | M | 69 | 9 jaar | |
Sergio Ermotti | M | 64 | 3 jaar | |
Giancarlo Mocchi | M | 84 | 3 jaar | |
Ulrich Lehner | M | 78 | 13 jaar | |
Wendelin Wiedeking | M | 72 | 11 jaar | |
Thomas Ebeling | M | 65 | 12 jaar | |
Pierre Landolt | M | 77 | 22 jaar | |
Carlos Eduardo Represas de Almeida | M | 78 | 7 jaar | |
Margot A. Scheltema | M | 69 | 8 jaar | |
Renato Fassbind | M | 69 | 11 jaar | |
David Cole | M | 62 | 10 jaar | |
Dirk van de Put | M | 63 | 1 jaar | |
Markus Enzelberger | M | 55 | 18 jaar | |
Julia Higgins | M | 82 | 6 jaar | |
Antonio Trius Oliva | M | 68 | - | |
Walter Kielholz | M | 73 | 32 jaar | |
Werner J. Bauer | M | 73 | - | |
Mary Francis | F | 75 | 5 jaar | |
Mun Tak Yang | F | 70 | - | |
Daniel Camus | M | 70 | 12 jaar | |
Metin Colpan | M | 69 | 8 jaar | |
Kuo Fung Ch'ien | M | 73 | 14 jaar | |
Richard Sykes | M | 79 | 10 jaar | |
Carl Robert Henrikson | M | 76 | 6 jaar | |
Gerhard Mayr | M | 78 | 7 jaar | |
Trevor Manuel | M | 68 | 5 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Zwitserland | 87 | 87.00% |
Duitsland | 11 | 11.00% |
Verenigde Staten | 6 | 6.00% |
Nederland | 1 | 1.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Hans Jörg Reinhardt
- Persoonlijk netwerk